Global HLA Typing Market Size (2024 - 2029)

The HLA typing market is anticipated to experience growth driven by factors such as the increasing prevalence of genetic diseases and the rising number of organ transplants. The market's expansion is further supported by advancements in HLA typing products and initiatives from key players introducing innovative solutions. The COVID-19 pandemic initially boosted the market due to the application of HLA typing in assessing disease severity, but growth is stabilizing as restrictions ease. Awareness campaigns and genetic testing initiatives are also contributing to market growth, despite challenges like small study populations, ethical concerns, and a stringent regulatory environment.

Market Size of Global HLA Typing Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
HLA Typing Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 0.75 Billion
Market Size (2029) USD 1.06 Billion
CAGR (2024 - 2029) 7.15 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

HLA Typing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

HLA Typing Market Analysis

The Global HLA Typing Market size is estimated at USD 0.75 billion in 2024, and is expected to reach USD 1.06 billion by 2029, growing at a CAGR of 7.15% during the forecast period (2024-2029).

COVID-19 impacted the HLA typing market to a great extent due to the use of HLA typing in identifying the severity of COVID-19 diseases. For instance, according to a study published in 2021 by the European Journal of Medical Research, the HLA-A*11:01, HLA-B*51:01, and HLA-C*14:02 alleles were significantly associated with severe disease or worse outcomes. This led to increased adoption of HLA typing for COVID-19 patients to understand the severity of the disease, driving the market growth. However, the market growth is stabilizing in the current scenario after COVID-19 as the worldwide restrictions have eased down and disease screening services have been resumed.

The factors such as the growing burden of genetic diseases and the increasing number of organ transplants aid as a major contributors to the market growth. Furthermore, advancements in the products related to HLA typing are also expected to boost market growth.

According to the CDC data updated in May 2022, Sickle Cell Disease (SCD) affects approximately 100,000 Americans in 2021. Furthermore, according to news-medical.net updated in August 2022, thalassemia affects around 4.4 out of every 10,000 live births throughout the world every year. Such a high prevalence of genetic diseases across the globe will lead to increased adoption of HLA testing for the identification of genetic diseases, driving market growth.

Furthermore, rising initiatives from the key market players for the launch of innovative products into the market will further be expected to drive the growth of this market. For instance, in November 2021, NGeneBio a South Korean diagnostics firm received CE-IVD marking for its next-generation sequencing-based human leukocyte antigen (HLA) typing assay. This HLAaccuTest detects 11 HLA gene loci to verify the histocompatibility between bone marrow or organ donors and recipients before transplantation. This will lead to increased adoption of HLA typing tests during organ and bone marrow transplantation propelling the market growth.

In addition, rising awareness of HLA typing is also expected to bolster market growth. For instance, in August 2021, a free HLA typing test camp was conducted at Dr. Vinky Rughwani Thalassemia and Sickle Cell Center in collaboration with Sankalp India Foundation. Such campaigns will therefore lead to increased adoption of HLA typing for genetic testing, driving the market growth.

Thus, the rising prevalence of diseases and the developments in HLA typing are expected to drive market growth. However, small size of study population and ethical concern and stringent regulatory framework are expected to hinder the growth of the market.

HLA Typing Industry Segmentation

HLA typing is referred to as genetic testing that identifies variations in the immune system of the body. This test is used to match patients and donors for bone marrow or cord blood transplants. HLA typing is used is to find out which people will be able to provide the safest tissue transplant. The HLA Typing Market is segmented By Product Type (Instruments, Reagents and Consumables, and Software and Services), Application (Diagnosis, Research) End User (Hospitals, Research Laboratories, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product and Service
Instruments
Reagents and Consumables
Softwares and Services
By Application
Diagnosis
Research
By End User
Hospitals
Research Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global HLA Typing Market Size Summary

The HLA typing market is poised for significant growth, driven by the increasing prevalence of genetic diseases and the rising number of organ transplants. The market experienced a surge in demand during the COVID-19 pandemic, as HLA typing was utilized to assess the severity of the disease, but has since stabilized with the easing of global restrictions. Advancements in HLA typing technologies and products are expected to further propel market expansion. The high incidence of genetic disorders such as sickle cell disease and thalassemia is anticipated to boost the adoption of HLA testing for genetic disease identification. Additionally, initiatives by key market players to introduce innovative products, such as next-generation sequencing-based assays, are expected to enhance the market's growth trajectory.

The hospital segment is projected to witness substantial growth due to the increasing number of organ transplants and the development of advanced medical infrastructure. Hospitals are actively conducting camps and programs to raise awareness and encourage bone marrow donations, which is expected to drive the adoption of HLA testing in these settings. North America is anticipated to dominate the market, supported by government initiatives and substantial funding for organ transplantation. The region's market growth is further bolstered by the launch of new HLA products by prominent players. The market remains slightly fragmented, with numerous biotechnological companies contributing to the competitive landscape, including key players like Thermofisher Scientific Inc., Qiagen, and Illumina Inc.

Explore More

Global HLA Typing Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Burden of Genetic Diseases

      2. 1.2.2 Increasing Number of Organ Transplantation

      3. 1.2.3 Rising Government Initiatives Related to Advanced Diagnostics

    3. 1.3 Market Restraints

      1. 1.3.1 Small Size of Study Population and Ethical Concern

      2. 1.3.2 Stringent Regulatory Framework

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product and Service

      1. 2.1.1 Instruments

      2. 2.1.2 Reagents and Consumables

      3. 2.1.3 Softwares and Services

    2. 2.2 By Application

      1. 2.2.1 Diagnosis

      2. 2.2.2 Research

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Research Laboratories

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global HLA Typing Market Size FAQs

The Global HLA Typing Market size is expected to reach USD 0.75 billion in 2024 and grow at a CAGR of 7.15% to reach USD 1.06 billion by 2029.

In 2024, the Global HLA Typing Market size is expected to reach USD 0.75 billion.

HLA Typing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)